Research shows proteomics can be used to predict evolution of triple negative breast

[News]

The rarest, but also the most aggressive and hard to treat form of breast cancer, is known as triple negative. For this type of cancer, researchers have so far been unable to identify markers that can classify patients by prognosis or probability of responding to different treatments.

More... (https://www.news-medical.net/news/20180829/Research-shows-proteomics-can-be-used-to-predict-evolution-of-triple-negative-breast-cancer.aspx)